Shirley A.A. Beresford

Professor Emeritus, Epidemiology

PhD, University of London (UK), 1981
BA/MA, Mathematics, University of Cambridge (UK), 1974
MSc, Mathematical Statistics, University of Sussex (UK), 1971



Faculty Bio Fred Hutch Page Publications (PubMed)

Dr. Beresford’s research interests are in the areas of nutritional epidemiology, social epidemiology, and chronic disease prevention. Her work is specifically designed to improve the scientific basis for public health policy and recommendations concerning dietary intake, physical activity, and folic acid status. She has been Principal Investigator on numerous individual and group randomized trials of dietary behavior intervention. Her research focus in the science of changing behavior on a population level has involved many interdisciplinary collaborations. The development and evaluation of obesity prevention interventions in work sites, using rigorous group randomized trial design and collaborative principles with participating work sites, provides one such example.

Dr. Beresford is affiliate investigator with the Clinical Nutrition Research Unit and member of the Fred Hutchinson Cancer Center in Cancer Prevention and Epidemiology.

Barbara Bruemmer

Senior Lecturer Emeritus, Epidemiology

PhD Epidemiology, University of Washington, 1993
MS Nutrition, University of Washington, 1983


Michael Rosenfeld

Professor, Environmental and Occupational Health Sciences
Professor, Pathology

PhD, Nutritional Science, University of Wisconsin
MS,Cell Biology, University of Vermont



Faculty Page

Dr. Michael Rosenfeld studies nutrition and cardiovascular disease, the role of nutrition in regulation of gene expression, lipid and lipoprotein metabolism, and the pathology of atherosclerosis. The current focus of the Rosenfeld Lab is on the accelerated vascular disease associated with obesity, type 2 diabetes, and chronic kidney disease. Specifically, the lab is studying the potential roles of the bone-related proteins osteoprotegerin, receptor activator of NFkB, and receptor activator of NFkB ligand in mediating the accelerated vascular calcification and atherosclerosis that occur in people with chronic kidney disease. The lab is also doing proteomic and genomic discovery studies with macrophages from uremic humans and mice to unveil new therapeutic pathways for chronic kidney disease. Dr. Rosenfeld also studies the roles of air pollution exposure and respiratory infection on atherosclerosis.